An at-risk group points to the possibility that the disease may be associated with the risk of vital substance (micronutrient) deficiency. Multiple sclerosis (MS) complaint indicates vital nutrient (macro- and micronutrient) deficiency for:
- Vitamin B12
- Omega-3 fatty acid docosahexaenoic acid
- Omega-3 fatty acid eicosapentaenoic acid
- Amino acid tryptophan
Within the framework of micronutrient medicine (vital substances), the following vital substances (micronutrients) are used for prevention (prevention):
- Vitamin D
Within the framework of micronutrient medicine (vital substances), the following vital substances (macro- and micronutrients) are used for supportive therapy:
- Vitamin B12
- Omega-3 fatty acid docosahexaenoic acid
- Omega-3 fatty acid eicosapentaenoic acid
- Amino acid tryptophan
The above vital substance recommendations (micronutrients) were created with the help of medical experts. All statements are supported by scientific studies with high levels of evidence. For a therapy recommendation, only clinical studies with the highest degrees of evidence (grade 1a/1b and 2a/2b) were used, which due to their high significance prove the therapy recommendation. These data are updated at certain intervals.
* Vital nutrients (macro- and micronutrients) include vitamins, minerals, trace elements, essential amino acids, essential fatty acids, etc.
